BCL2L11 and prostate carcinoma: In vitro resveratrol downregulated the expressions of Bcl-2 and Bcl-XL and upregulated the expressions of p53, Bax, Bak, PUMA, Noxa, and Bim at mRNA and protein levels in prostate cancer cells [41].